Wharton’s Jelly Mesenchymal Stem Cells as Candidates for Beta Cells Regeneration: Extending the Differentiative and Immunomodulatory Benefits of Adult Mesenchymal Stem Cells for the Treatment of Type 1 Diabetes
2010 ◽
Vol 7
(2)
◽
pp. 342-363
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2021 ◽
Vol 47
(1)
◽
pp. 320-328
Keyword(s):
2021 ◽
Keyword(s):